ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC

NCT04032847 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Advanced Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: ATL001
DRUG: Pembrolizumab

Sponsor

Achilles Therapeutics UK Limited